Chemokine Expression-Based Endotype Clustering of Chronic Rhinosinusitis.
asthma
chemokines
chronic rhinosinusitis
cytokines
endotyping
nasal polyps
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
18 Apr 2022
18 Apr 2022
Historique:
received:
18
02
2022
revised:
14
04
2022
accepted:
15
04
2022
entrez:
23
4
2022
pubmed:
24
4
2022
medline:
24
4
2022
Statut:
epublish
Résumé
Chronic rhinosinusitis (CRS) with (CRSwNP) or without nasal polyps (CRSsNP) is a persistent, heterogeneous inflammatory condition affecting the upper respiratory tract. The present study aimed to improve the characterization of CRS endotypes based on the chemokine and cytokine expression pattern in the CRS tissues. Concentrations of chemokines and cytokines were measured in tissues from nasal biopsies obtained from 66 CRS patients and 25 control subjects using multiplexing or single analyte technologies. Cluster analysis based on the concentration of type-1 (MCP-3/CCL7, MIP-1 α/CCL3), type-2 (IL-5, MCP-3/CCL7, MIP-1 α/CCL3, TARC/CCL17, PARC/CCL18, IP-10/CXCL10, ECP), and type-3 (IL-22) chemokines and cytokines identified six CRS endotypes (clusters). Cluster 1 (type-3) and 2 (type-1) were associated with a low prevalence of nasal polyps, Cluster 3 (type-1, -2, -3) and Cluster 4 (type-2, -3, medium IL-22) with medium, and Cluster 5 (type-2, -3, high Il-22) and Cluster 6 (type-2) with high prevalence of nasal polyps. Asthma was highly prevalent in Cluster-6. Our findings add to the existing knowledge of CRS endotypes and may be useful for the clinical decision-making process. The advancement of biologics therapy for upper respiratory tract disorders rationalizes the personalized diagnostic approach to warrant a successful treatment and monitoring of CRS.
Identifiants
pubmed: 35455762
pii: jpm12040646
doi: 10.3390/jpm12040646
pmc: PMC9025930
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Rhinology. 2020 Apr 1;58(2):82-111
pubmed: 32226949
Lancet. 2019 Nov 2;394(10209):1638-1650
pubmed: 31543428
J Allergy Clin Immunol. 2021 Aug;148(2):327-335
pubmed: 33895002
Int J Biochem Cell Biol. 2004 Oct;36(10):1882-6
pubmed: 15203102
Acta Derm Venereol. 2017 Mar 10;97(3):325-331
pubmed: 27701668
Medicina (Kaunas). 2021 Mar 18;57(3):
pubmed: 33803540
Mediators Inflamm. 2019 Jan 15;2019:7138643
pubmed: 30766447
Allergy. 2011 Sep;66(9):1216-23
pubmed: 21605125
Cytokine. 1995 Feb;7(2):97-104
pubmed: 7780043
J Exp Med. 1998 Jan 5;187(1):129-34
pubmed: 9419219
J Exp Med. 1992 Dec 1;176(6):1489-95
pubmed: 1281207
J Allergy Clin Immunol. 2020 Sep;146(3):595-605
pubmed: 32524991
J Allergy Clin Immunol. 2011 Nov;128(5):1067-76.e1-6
pubmed: 21794904
Allergy. 2004 Dec;59(12):1243-58
pubmed: 15507091
Allergy Asthma Immunol Res. 2019 Mar;11(2):201-211
pubmed: 30661312
J Exp Med. 1998 Mar 16;187(6):875-83
pubmed: 9500790
Eur Respir J. 2019 Nov 7;54(5):
pubmed: 31439682
J Leukoc Biol. 1997 Nov;62(5):604-11
pubmed: 9365115
Cell. 2018 Aug 23;174(5):1054-1066
pubmed: 30142344
J Allergy Clin Immunol. 2016 May;137(5):1449-1456.e4
pubmed: 26949058
J Allergy Clin Immunol. 2019 Nov;144(5):1254-1264
pubmed: 31271788
Allergy. 2019 Apr;74(4):743-752
pubmed: 30488542
Immun Inflamm Dis. 2017 Sep;5(3):233-243
pubmed: 28474861
J Allergy Clin Immunol. 2016 Nov;138(5):1344-1353
pubmed: 27544740
Allergy. 2008 Apr;63 Suppl 86:8-160
pubmed: 18331513
Biochemistry. 2002 Aug 20;41(33):10418-25
pubmed: 12173928
PLoS One. 2018 May 10;13(5):e0197355
pubmed: 29746583
Cytokine Growth Factor Rev. 1999 Mar;10(1):61-86
pubmed: 10379912
Respir Med. 2013 Sep;107(9):1444-52
pubmed: 23831213
Allergy. 2012 Jan;67(1):91-8
pubmed: 22050239
J Exp Med. 2010 Jun 7;207(6):1293-305
pubmed: 20498020
Clin Exp Allergy. 2022 Feb;52(2):231-243
pubmed: 34854144
Lancet Respir Med. 2021 Oct;9(10):1141-1153
pubmed: 33872587
Clin Ter. 2017 Jan-Feb;168(1):e54-e58
pubmed: 28240764
Allergy Asthma Clin Immunol. 2016 Apr 27;12:19
pubmed: 27127525
Nat Immunol. 2016 Jan;17(1):57-64
pubmed: 26523868
J Allergy Clin Immunol Pract. 2019 Nov - Dec;7(8):2812-2820.e3
pubmed: 31128376
J Exp Med. 2013 Sep 23;210(10):1889-98
pubmed: 23999500
J Allergy Clin Immunol. 2021 Apr;147(4):1306-1317
pubmed: 33326802
J Allergy Clin Immunol. 2012 Jan;129(1):119-27.e1-9
pubmed: 21943944
Laryngoscope. 2009 Jun;119(6):1053-9
pubmed: 19296494
Allergy. 2019 Dec;74(12):2312-2319
pubmed: 31090937
Eur J Immunol. 2017 Apr;47(4):607-614
pubmed: 28295238
J Allergy Clin Immunol. 2012 Dec;130(6):1384-93
pubmed: 23102918
Allergy Asthma Proc. 2016 Jan-Feb;37(1):35-42
pubmed: 26831845
J Allergy Clin Immunol. 2021 Jan;147(1):29-36
pubmed: 33227318
Allergy Asthma Immunol Res. 2020 Nov;12(6):980-993
pubmed: 32935490
J Allergy Clin Immunol. 2008 Nov;122(5):961-8
pubmed: 18804271
Curr Opin Otolaryngol Head Neck Surg. 2019 Feb;27(1):14-19
pubmed: 30507689
J Allergy Clin Immunol. 2013 Jan;131(1):110-6.e1
pubmed: 23021878
Allergy. 2011 Jan;66(1):141-8
pubmed: 20659077
Allergy. 2020 Jan;75(1):148-157
pubmed: 31306495
Eur J Immunol. 1996 Aug;26(8):1919-25
pubmed: 8765040
Allergol Int. 2013 Dec;62(4):495-502
pubmed: 24153332
Exp Ther Med. 2020 Sep;20(3):2352-2360
pubmed: 32765714
J Asthma. 2014 Oct;51(8):847-54
pubmed: 24796647
Int J Mol Sci. 2021 Dec 30;23(1):
pubmed: 35008843
J Immunol. 2002 May 15;168(10):5278-86
pubmed: 11994485
Rhinology. 2006 Jun;44(2):145-50
pubmed: 16792175
Clin Exp Allergy. 2006 Jun;36(6):748-59
pubmed: 16776676
Clin Exp Allergy. 2003 Apr;33(4):531-7
pubmed: 12680872
Biochem Biophys Rep. 2017 Dec 09;13:27-31
pubmed: 29264403
J Allergy Clin Immunol. 2016 Oct;138(4):1098-1107.e3
pubmed: 27543072
Annu Rev Immunol. 2000;18:217-42
pubmed: 10837058
Immunity. 2019 Apr 16;50(4):871-891
pubmed: 30995504
J Otolaryngol. 1998 Oct;27(5):281-7
pubmed: 9800627